Desyncra™ – Rewiring the brain

Desyncra™ – Rewiring the brain

A new way to reduce symptoms

A new way to reduce symptoms

Sounds good. Feels better.

Sounds good. Feels better.


The Desyncra™ offering at a glance

German-based medical company Desyncra™ offers tremendous marketing opportunities through an all-new technology: Non-Invasive Neuromodulation. The groundbreaking technology was developed by a team of brain scientists, neurologists, engineers and IT-specialists led by medical device expert Dr Markus Haller.

Accessing the brain to open up cures for multiple neural conditions: Tomorrow is now!


Treatment systems
Components per system


Patent Families


Years of research




Clinical trials
Desyncra™ for Tinnitus
A new way to reduce tinnitus: More than 4000 patients have been successfully treated with this clinically tested acoustic CR® Neuromodulation. All tests show similar results: Desyncra™ For Tinnitus is successful in more than 75% of treated subjects.
Desyncra™ for Tremor
Desyncra for Tremor uses CR® Neuromodulation as a powerful tool to treat a range of movement disorders, for example; Parkinson’s disease related tremor, and other movement disorders such as dystonia and many other neurological conditions.
Desyncra™ for Migraine
Good news for patients with migraine: Desyncra has developed a treatment on the basis of CR® Neuromodulation to manage pain, aura and nausea through stimulating neural patterns in the brain using visual stimulation.
Desyncra™ Hearing Aid
Quite frequently, tinnitus patients are also hearing impaired. Our own full spectrum hearing aid device works perfectly with Desyncra for Tinnitus and provides its users with a first-class product that makes life easier.

Curing the condition, not just stopping symptoms

Desyncra™ systems are targeted: Propriety, Coordinated Reset, Non Invasive Neuromodulation. Accessing the brain to open up cures for multiple neural conditions.

Great things come
to those who sign up

Stay up to date with Desyncra’s newsletter featuring latest product updates, previews and more.

Sign up


Call us:
EU: +49 (0) 2641 912 – 8787
US: +1 844 444 – 2266